Livingstone Dispenses Exit Advice

Share this article: Twitter Facebook Print Share this page with a friend/colleague

January 2011

Livingstone’s Healthcare team has successfully completed the sale of Dispensing Solutions, Inc (‘DSI’) to PSS World Medical (‘PSS’), a publicly-traded distributor of medical supplies, equipment and pharmaceutical products to healthcare providers across the United States.

Jim Moskal, Managing Director at Livingstone Chicago, led the project and advised DSI and its private equity investor, HealthEdge Investment Partners. DSI is a leading provider of turn-key medication dispensing programs to physicians and facility-based healthcare providers that fill prescriptions at the point of care. Tampa-based HealthEdge specialises in backing high growth companies in the Healthcare sector and invested in DSI in September 2006.

Guy Bryant, CEO of DSI, commented: “Our executive team is eager to combine PSS’s extensive sales network and support infrastructure with DSI’s high quality dispensing offering and begin the Company’s next growth phase.”

Moskal added: “We worked closely with DSI for over two years and contemplated a number of strategic alternatives. Ultimately, a sale made the greatest sense and PSS was an extremely complementary strategic partner. The deal provided an excellent investment return to HealthEdge.”

Richard Fetterman, Partner at Livingstone London concluded: “The DSI deal is another banner deal for Livingstone’s cross-border Healthcare capability and comes quickly on the heels of the sale in January 2011 of pharmacovigilance consultancy WCI to Indian group TAKE Solutions.”

For further information contact:
Richard Fetterman, Partner, Livingstone London
T: 020 7484 4700
E: fetterman@livingstonepartners.co.uk

Jim Moskal, Managing Director, Livingstone Chicago
T: +1 312 670 5900
E: moskal@livingstonepartners.com